DCGI grants emergency use authorisation to India's first mRNA Covid-19 vaccine: Sources
Published
The Subject Expert Committee under India's drug regulator has found data submitted by Gennova Biopharmaceuticals "satisfactory".
Full ArticlePublished
The Subject Expert Committee under India's drug regulator has found data submitted by Gennova Biopharmaceuticals "satisfactory".
Full ArticleThe Drugs controller general of India (DCGI) is expected to give Emergency Use Authorisation to Gennova`s mRNA vaccine any time..
The Subject Expert Committee (SEC) in a meeting held on Friday recommended Emergency Use Authorisation (EUA) for India's first mRNA..